The antibacterial activity of selected Labiatae (Lamiaceae) essential oils against Brucella melitensis

Iranian Journal of Medical Sciences

Volumn 38, Issue 1, 2013, Pages 44-50

  Al Mariri, Ayman ^a   Safi, Mazen ^a  

^a DEPARTMENT OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Syrian Arab Republic)

Author keywords

Antibiotic resistance; Brucella melitensis; Brucellosis; Origanum

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; ESSENTIAL OIL; LEVOFLOXACIN; OFLOXACIN; PLANT EXTRACT; SPARFLOXACIN; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BROTH DILUTION; BRUCELLA MELITENSIS; BRUCELLOSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFICACY; IN VITRO STUDY; LAMIACEAE; LAVANDULA STOECHAS; LAVENDER; MENTHA; MENTHA PIPERIA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORIGANUM; ORIGANUM SYRIACUM; ROSEMARY; SALVIA; SALVIA PALESTINA; THYMUS SYRIACUS;

EID: 84875507433     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Grilló MJ, De Miguel MJ, Muñoz PM, Marín CM, Ariza J, Blasco JM. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice. J Antimicrob Chemother. 2006;58:622-6. doi: 10.1093/jac/dkl289. PubMed PMID: 16849379.
2. Gul ST, Khan A. Epidemiology and epizootology of brucellosis: a review. Pakistan Vet J. 2007;27:145-51.
3. Groussaud P, Shankster SJ, Koylass MS, Whatmore AM. Molecular typing divides marine mammal strains of Brucella into at least three groups with distinct host preferences. J Med Microbiol. 2007;56:1512-8. doi: 10.1099/jmm.0.47330-0. PubMed PMID: 17965354
4. Mantur BG, Amarnath SK. Brucellosis in India - a review. J Biosci. 2008;33:539-47. doi: 10.1007/s12038-008-0072-1. PubMed PMID: 19208979.
5. Valenza G, Kallmann B, Berend A, Mlynski R, Nöckler K, Kurzai O, et al. Isolation of Brucella melitensis from a patient with hearing loss. Eur J Clin Microbiol Infect Dis. 2006;25:67-8. doi: 10.1007/s10096-006-0084-4. PubMed PMID: 16418830.
6. st century: the Ioannina recommendations. PLoS Med. 2007;4:e317. doi: 10.1371/journal.pmed.0040317. PubMed PMID: 18162038; PubMed Central PMCID: PMC2222927
7. Magoffin RL, Spink WW. The protection of intracellular brucella against streptomycin alone and in combination with other antibiotics. J Lab Clin Med. 1951;37:924-30. PubMed PMID: 14850823.
8. Solera J, Martínez-Alfaro E, Espinosa A. Recognition and optimum treatment of brucellosis. Drugs. 1997;53:245-56. doi: 10.2165/00003495-199753020-00005. PubMed PMID: 9028744.
9. Joint FAO/WHO expert committee on brucellosis. World Health Organ Tech Rep Ser. 1986;740:1-132. PubMed PMID: 3097967
10. Maves RC, Castillo R, Guillen A, Espinosa B, Meza R, Espinoza N, et al. Antimicrobial susceptibility of Brucella melitensis isolates in Peru. Antimicrob Agents Chemother. 2011;55:1279-81. doi: 10.1128/AAC.00979-10. PubMed PMID: 21199926; PubMed Central PMCID: PMC3067062.
11. Solera J. Update on brucellosis: therapeutic challenges. Int J Antimicrob Agents. 2010;36:S18-20. doi: 10.1016/j. ijantimicag.2010.06.015. PubMed PMID: 20692127.
12. Mert A, Kocak F, Ozaras R, Tabak F, Bilir M, Kucukuglu S, et al. The role of antibiotic treatment alone for the management of Brucella endocarditis in adults: a case report and literature review. Ann Thorac Cardiovasc Surg. 2002;8:381-5. PubMed PMID: 12517300.
13. Yilmaz E, Parlak M, Akalin H, Heper Y, Ozakin C, Mistik R, et al. Brucellar spondylitis: review of 25 cases. J Clin Rheumatol. 2004;10:300-7. PubMed PMID: 17043537.
14. Pappas G, Christou L, Akritidis N, Tsianos EV. Quinolones for brucellosis: treating old diseases with new drugs. Clin Microbiol Infect. 2006;12:823-5. doi: 10.1111/j.1469-0691.2006.01442.x. PubMed PMID: 16882286.
15. Gogia A, Dugga L, Dutta S. An unusual etiology of PUO. J Assoc Physicians India. 2011;59:47-9. PubMed PMID: 21751665.
16. Valdezate S, Navarro A, Medina-Pascual MJ, Carrasco G, Saéz-Nieto JA. Molecular screening for rifampicin and fluoroquinolone resistance in a clinical population of Brucella melitensis. J Antimicrob Chemother. 2010;65:51-3. doi: 10.1093/jac/dkp389. PubMed PMID: 19861338.
17. Karabay O, Sencan I, Kayas D, Sahin I. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]. BMC Infect Dis. 2004;4:18. PubMed PMID: 15214959; PubMed Central PMCID: PMC459220.
18. Falagas ME, Bliziotis IA. Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies. Antimicrob Agents Chemother. 2006;50:22-33. doi: 10.1128/AAC.50.1.22-33.2006. PubMed PMID: 16377662; PubMed Central PMCID: PMC1346783.
19. Aboaba OO, Smith SI, Olude FO. Antibacterial effect of edible plant extract on Escherichia coli O157:H7. Pakistan Journal of Nutrition. 2006;5:325-7.
20. Mirjana S, Nada B, Valerija D. Variability of Satureja cuneifolia Ten. essential oils and their antimicrobial activity depending on the stage of development. European Food Research and Technology. 2004;218:367-71. doi: 10.1007/s00217-003-0871-4.
21. Tamokou Jde D, Kuiate JR, Tene M, Kenla Nwemeguela TJ, Tane P. The Antimicrobial Activities of Extract and Compounds Isolated from Brillantaisia lamium. Iran J Med Sci. 2011;36:24-31. PubMed PMID: 23365474; PubMed Central: PMC3559120.
22. Gatsing D, Tchakoute V, Ngamga D, Kuiate JR, Tamokou Jde D, Nji-Nkah BF, et al. In Vitro Antibacterial Activity of Crinum Purpurascens Herb. Leaf Extract Against the Salmonella Species Causing Typhoid Fever and Its Toxicological Evaluation. Iran J Med Sci. 2009;34:126-36.
23. Adiguzel A, Ozer H, Kilic H, Cetin B. Screening of antimicrobial activity of essential oil and methanol extract of Satureja hortensis on foodborne bacteria and fungi. Czech J Food Sci. 2007;25:81-9.
24. Marino M, Bersani C, Comi G. Impedance measurements to study the antimicrobial activity of essential oils from Lamiaceae and Compositae. Int J Food Microbiol. 2001;67:187-95. doi: 10.1016/S0168-1605(01)00447-0. PubMed PMID: 11518428.
25. Seyyednejad SM, Maleki S, Mirzaei Damabi N, Motamedi H. Antibacterial activity of Prunus mahaleb and Parsley (Petroselinum crispum) against some pathogen. Asian J Biol Sci. 2008;1:51-5. doi: 10.3923/ajbs.2008.51.55
26. Seyyednejad SM, Motamedi H. A review on native medicinal plants in Khuzestan, Iran with antibacterial properties. Int J Pharmacol. 2010;6:551-60. doi: 10.3923/ijp.2010.551.560.
27. Motamedi H, Darabpour E, Gholipour M, Seyyed Nejad SM. In vitro assay for the anti-Brucella activity of medicinal plants against tetracycline-resistant Brucella melitensis. J Zhejiang Univ Sci B. 2010;11:506-11. doi: 10.1631/jzus.B0900365. PubMed PMID: 20593515; PubMed Central PMCID: PMC2897020.
28. Al-Mariri A. Ultraviolet C lethal effect on Brucella melitensis. New Microbiol. 2008;31:47-55. PubMed PMID: 18437841
29. Bricker BJ. Diagnostic strategies used for the identification of Brucella. Vet Microbiol. 2002;90:433-4. doi: 10.1016/S0378-1135(02)00227-4. PubMed PMID: 12414162.
30. Council of Europe. European Pharmacopoeia. 7th ed. Strasbourg: Worldwide Book Service; 2011. p. 99.
31. National Committee for Clinical Laboratory Standards. Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Sixth Edition. NCCLS document M7-A6. Wayne: National Committee for Clinical Laboratory Standards; 2003
32. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. Antimicrobial susceptibility testing. In: Color atlas and textbook of diagnostic microbiology. 5th ed. Philadelphia: Lippincott-Raven; 1997. p. 785-856.
33. Marianelli C, Ciuchini F, Tarantino M, Pasquali P, Adone R. Genetic bases of the rifampin resistance phenotype in Brucella spp. J Clin Microbiol. 2004;42:5439-43. doi: 10.1128/ JCM.42.12.5439-5443.2004. PubMed PMID: 15583262; PubMed Central PMCID: PMC535235.
34. Hassawi D, Kharma A. Antimicrobial activity of some medicinal plants against Candida albicans. J Biol Sci. 2006;6:109-14.
35. Brul S, Coote P. Preservative agents in foods. Mode of action and microbial resistance mechanisms. Int J Food Microbiol. 1999;50:1-17. doi: 10.1016/S0168-1605(99)00072-0. PubMed PMID: 10488839.
36. Holley RA, Patel D. Improvement in shelf-life and safety of perishable foods by plant essential oils and smoke antimicrobials. Food Microbiol. 2005;22:273-92. doi: 10.1016/j.fm.2004.08.006.
37. Helander IM, Alakomi HL, Latva-Kala K, Mattila-Sandholm T, Pol I, Smid EJ, et al. Characterization of the action of selected essential oil components on gram-negative bacteria. J Agric Food Chem. 1998;46:3590-5. doi: 10.1021/jf980154m.
38. Senhaji O, Faid M, Kalalou I. Inactivation of Escherichia coli O157:H7 by essential oil from Cinnamomum zeylanicum. Braz J Infect Dis. 2007;11:234-6. doi: 10.1590/S1413-86702007000200013. PubMed PMID: 17625768.
39. Inouye S, Takizawa T, Yamaguchi H. Antibacterial activity of essential oils and their major constituents against respiratory tract pathogens by gaseous contact. J Antimicrob Chemother. 2001;47:565-73. doi: 10.1093/jac/47.5.565. PubMed PMID: 11328766
40. Reuben KD, Abdulrahman FI, Akan JC, Usman H, Sodipo OA, Egwu GO. Phytochemical screening and in vitro antimicrobial investigation of the methanolic extract of Croton zambesicus Muell ARG, stem bark. Eur J Sci Res. 2008;23:134-40.
41. Darabpour E, Poshtkouhian Bavi A, Motamedi H, Seyed Nejad SM. Antibacterial activity of different parts of peganum harmala L. growing in Iran against multi-drug resistant bacteria. EXCLI Journal. 2011;10:252-63.
42. Shapouri R, Rahnema M. Evaluation of antimicrobial effect of hops extracts on intramacrophages Brucella abortus and B. melitensis. Jundishapur J Microbiol. 2011;4:S51-8.